Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in: European Surgery 6/2016

01.12.2016 | DFP-Fortbildung

Bariatrische Eingriffe in der Therapie des Diabetes mellitus Typ II

verfasst von: Stephan Kriwanek, Nada Loibner, Philipp Patri, Mathias Hofmann

Erschienen in: European Surgery | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Mithilfe bariatrischer Eingriffe kann der adipositasassoziierte Diabetes mellitus Typ II günstig beeinflusst werden. Der antidiabetische Effekt ist durch eine Erhöhung der Insulinsensitivität bedingt. Ausmaß und Dauer der Remission hängen wesentlich von dem Schweregrad und der Dauer des Diabetes zum Zeitpunkt der Operation ab. Am meisten profitieren adipöse Patientinnen und Patienten mit einem Prädiabetes. Bariatrische Eingriffe sind bei massiv adipösen Diabetikern wirksamer als nichtoperative Verfahren.
Vorheriger Artikel The importance of diagnostic awareness of groove pancreatitis
Nächster Artikel Erratum to: Surgical approach is superior to palliative treatment in oligometastatic lung cancer
Literatur
1.
Pories W. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93:89.CrossRef
2.
Dixon J, le Roux, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet. 2012;379:2300–11.CrossRefPubMed
3.
Angrisani L, et al. Bariatric surgery worldwide. Obes Surg. 2013;2015(25):1822.
4.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery. A systematic review and meta-analysis. JAMA. 2004;292:1724.CrossRefPubMed
5.
Buchwald H, Estok R, Fahrbach K. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621.CrossRefPubMed
6.
Chang S, Stoll C, Song J. The effectiveness and risks of bariatric surgery: an updated systemic review and meta-analysis 2003–2012. JAMA Surg. 2014;(149):275. doi:10.​1001/​jamasurg.​2013.​3654.
7.
Ramanan B, Gupta P, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214:892–900.CrossRefPubMed
8.
Jafari MN, Fafari F, Young M, et al. Volume and outcome relationship in bariatric surgery in the laparoscopic era. Surg Endosc. 2013;27:4539.CrossRefPubMed
9.
Sjöström L, Lindroos A, Peltonen P, et al. Lifestyle, diabetes, and cardiovascular riks factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683.CrossRefPubMed
10.
Sjöström L, Narbro K, Sjöström K, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741.CrossRefPubMed
11.
Stefater M, Wilson-Perez W, Chambers A, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33:595.CrossRefPubMedPubMedCentral
12.
Borg C, Roux C, Ghatei S. Progressive rise in gut hormone levels after Roux-en-y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210.CrossRefPubMed
13.
Ramon J, Salvans S, Crous X, et al. Effect of Roux-en-Y bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomized trial. J Gastrointest Surg. 2012;16:116–22.CrossRef
14.
Jacobsen S, Olesen S, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22:1084–96.CrossRefPubMed
15.
Dar M, Chapman W, Pender J, et al. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass? Obes Surg. 2012;22:1077–83.CrossRefPubMed
16.
Buchwald H. Consensus conference statement: Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg. 2005;200:593.CrossRefPubMed
17.
Belachew S, Angrisani L, Belachew M, et al. Obesity surgery. Evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19:220.
18.
Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European guidelines of surgery for severe obesity. Obes Surg. 2007;17:260.CrossRefPubMed
19.
Mechanick J, Kushner R, Sugerman H. American Associaton of Clincal Endocrinolgists, the Obesity Society and ASMBS guidelines for clinical practice of the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Rel Dis. 2008;4:109.CrossRef
20.
Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie. S3 Leitlinie Chirurgie der Adipositas.
21.
American Diabetes Association. Standards of medical care in diabetes – 2009. Diabetes Care. 2009;32(suppl 1):13.CrossRef
22.
Pories W, Swanson M, MacDonald K. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;3:339.CrossRef
23.
24.
Frühbeck G. Bariatric and metabolic surgery: a shift in elegibility and success criteria. Nat Rev Endocrinol. 2015;11:465.CrossRefPubMed
25.
Dixon J, O’Brien P, Playfaire J, et al. Adjustable gastric banding and conventional therapy of type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316.PubMed
26.
Schauer P, Bhatt D, Kirwan J, et al. Bariatric surgery versus intensive medical therapy for diabetes – 3 year outcomes. N Engl J Med. 2014;370:2002.CrossRefPubMed
27.
Mingrone G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial. Lancet. 2015;386:964.CrossRefPubMed
28.
Ikramuddin S, Korner J, Lee W, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. JAMA. 2013;309:2240.CrossRefPubMedPubMedCentral
29.
Adams T, Davidson L, Litwin S, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2013;308:1122.CrossRef
30.
31.
Campanile F, Boru C, Rizello M. Acute complications after laparoscopic bariatric procedures: update for the general surgeon. Langenbecks Arch Surg. 2013;398:669.CrossRefPubMed
32.
33.
Vest A, Henegahn H, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2013;98:1763.CrossRef
34.
Sjöström L, Petonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297.CrossRefPubMed
35.
Carlsson L, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.CrossRefPubMed
36.
Fridman A, Moon R, Cozacov Y, et al. Procedure-related morbidity in bariatric surgery: a retrospective short- and mid-term follow-up of a single institution of the American College of Surgeons Bariatric Surgery Centers of Excellence. J Am Coll Surg. 2013;271:614.CrossRef
37.
Ceppa E, Ceppa D, Omotosho P, et al. Algorithm to diagnose etiology of hypoglycemia after Roux-en-Y gastric bypass for morbid obesity: case series and review of the literature. Surg Obes Realt Dis. 2012;8:641–7.CrossRef
38.
Laurenius A, Obers T, Näslund J, et al. Dumping syndrome following gastric bypass: validation of the dumpling symptom rating scale. Obes Surg. 2013;23:740.CrossRefPubMed
39.
Kefurt R, et al. Hypoglycemia after Roux-en-Y gastric bypass: detection rates of continuous glucose monitoring versus mixed meal test. SOARD. 2015;11:564.
40.
Vix M, Liu K, Diana M, et al. Impact of Roux-en Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short term results from a prospective randomized clinical trial. Surg Endosc. 2013;28:821. doi:10.​1007/​s00464-013-3276-x.CrossRefPubMed
41.
Hewitt S, Sovik T, Aasheim E, et al. Secondary hyperparathyroidism, vitamin D sufficiency and serum calcium 5 yeras after gastric bypass and duodenal switch. Obes Surg. 2013;23:384.CrossRefPubMed
42.
Serrot F, Corman R, Miller C, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index < 35 kg/m2. Surgery. 2011;150:684.CrossRefPubMed
43.
Lee W, Hur K, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–52.CrossRefPubMed
44.
DePaula A, Stival A, de Paula C, et al. Surgical treatment of type 2 diabetes patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg. 2012;16:967–76.CrossRefPubMed
45.
Astiarraga B, Gastaldelli A, Muscelli E. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab. 2013;98:2765.CrossRefPubMed
46.
Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes. JAMA. 2013;309:2250.CrossRefPubMed
47.
Parikh M, Issa R, Vieira D, et al. Role of bariatric surgery as treatment for type 2 diabetes in patients who do not meet current NIH criteria: a systematic review and meta-analysis. J Am Coll Surg. 2013;217:527.CrossRefPubMed
48.
ASMBS statement. Bariatric surgery in class I obesity. Surg Obes Rel Dis. 2013;9:e1–e10.CrossRef
49.
Lebovitz H. Metabolic surgery for type 2 diabetes with BMI < 35. An endocrinologist’s perspective. Obes Surg. 2013;23:800.
50.
Scharf K, Morton J. Metabolic surgery for type 2 diabetes with BMI < 35. A surgeons perspective. Obes Surg. 2013;23:800.
51.
Inabnet W, Winegar D, Sherif B, et al. Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. J Am Coll Surg. 2012;214:550–7.CrossRefPubMed
Metadaten
Titel
Bariatrische Eingriffe in der Therapie des Diabetes mellitus Typ II
verfasst von
Stephan Kriwanek
Nada Loibner
Philipp Patri
Mathias Hofmann
Publikationsdatum
01.12.2016
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 6/2016
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-016-0446-9

Weitere Artikel der Ausgabe 6/2016

European Surgery 6/2016 Zur Ausgabe

original article

Experimental nerve transfer model in the rat forelimb

original article

Missed injuries in patients with abdominal gunshot trauma: risk factors and mortality rates

case report

The importance of diagnostic awareness of groove pancreatitis

Erratum

Erratum to: Surgical approach is superior to palliative treatment in oligometastatic lung cancer

Original Article

Surgical approach is superior to palliative treatment in oligometastatic lung cancer

original article

Viability of five different pre- and intraoperative imaging methods for autologous breast reconstruction